In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR), this scoping review was conducted. MEDLINE and EMBASE databases were consulted for relevant search literature up to March 2022. In order to incorporate any omitted articles, a separate manual search was performed, supplementing the initial database search process.
The selection of studies and the extraction of data were conducted in a manner that was both paired and independent. No restrictions were placed on the language of publication for the manuscripts included in the collection.
The analysis of 17 studies comprised 16 case reports, along with a single, separate retrospective cohort study. All of the research projects employed VP, exhibiting a median drug infusion time of 48 hours (interquartile range 16-72), and displaying a DI incidence of 153%. Evidence for DI was found in diuresis output and the concurrent presence of hypernatremia or changes in serum sodium concentration, with a median of 5 hours (IQR 3-10) between VP discontinuation and symptom onset. Fluid management and desmopressin constituted the core of DI treatment strategies.
Among 17 studies on VP withdrawal, 51 patients presented with DI; however, the methods of diagnosis and management differed significantly between reports. We derive, from the available data, a diagnostic proposition and a treatment algorithm for managing DI in ICU patients following VP discontinuation. read more This subject demands a quick and effective approach involving multicentric collaborative research to procure high-quality data.
Persico RS, accompanied by Viana MV and Viana LV. Diabetes Insipidus: A Scoping Review on the Sequelae of Vasopressin Withdrawal. Within the 2022 July issue of the Indian Journal of Critical Care Medicine, volume 26, number 7, articles are presented on pages 846 to 852.
Persico RS, Viana MV, and Viana LV. The Impact of Vasopressin Withdrawal on Diabetes Insipidus: A Scoping Review of the Literature. In 2022, the 7th issue of Indian Journal of Critical Care Medicine published articles on pages 846 through 852.
Left and/or right ventricular systolic and/or diastolic dysfunction is a common consequence of sepsis, resulting in adverse outcomes. Echocardiography (ECHO) enables the identification of myocardial dysfunction, which subsequently allows for the initiation of early intervention plans. The current body of Indian literature displays a shortage of accurate data on the true incidence of septic cardiomyopathy and how it affects ICU patient outcomes.
An observational study, prospective in design, examined patients admitted to the ICU of a tertiary care hospital in North India, all consecutively diagnosed with sepsis. The intensive care unit (ICU) outcome of these patients was analyzed subsequent to the performance of echocardiography (ECHO) to determine left ventricular (LV) dysfunction 48 to 72 hours after admission.
The rate of left ventricular dysfunction amounted to 14% of the total cases. 4286% of patients showed isolated systolic dysfunction, 714% showed isolated diastolic dysfunction, and a staggering 5000% of the patients experienced combined left ventricular systolic and diastolic dysfunctions. Group I (patients without left ventricular dysfunction) demonstrated an average mechanical ventilation duration of 241 to 382 days, in contrast to group II (patients with left ventricular dysfunction), whose average was 443 to 427 days.
A list of sentences is returned by this JSON schema. All-cause ICU mortality in group I reached 11 (1279%), while group II exhibited a mortality rate of 3 (2143%).
The JSON schema will list sentences as requested. In group I, the average ICU stay was 826.441 days, whereas group II patients stayed in the ICU for an average of 1321.683 days.
Our conclusion highlighted sepsis-induced cardiomyopathy (SICM) as a rather widespread issue with significant clinical implications in the ICU setting. The time spent in the intensive care unit (ICU) and the likelihood of death from any cause in the ICU are both longer for patients with SICM.
Bansal S, Varshney S, and Shrivastava A conducted a prospective, observational study to establish the prevalence and clinical outcomes of sepsis-induced cardiomyopathy in an intensive care unit. In 2022, the Indian Journal of Critical Care Medicine, within its seventh volume, contained articles ranging from page 798 to page 803.
A prospective observational investigation by Bansal S, Varshney S, and Shrivastava A determined the rate of onset and treatment success of sepsis-induced cardiomyopathy within an intensive care unit. Within the 2022 Indian Journal of Critical Care Medicine, volume 26, issue 7, readers will find articles spanning pages 798-803.
Organophosphorus (OP) pesticides find widespread application in both industrialized and less developed nations. Organophosphorus poisoning is most frequently encountered through occupational, accidental, and self-inflicted exposures. Rarely are cases of toxicity associated with parenteral injections documented, with a minimal number of existing case reports.
A swelling on the left leg was the site of a parenteral injection of 10 mL of OP compound, specifically Dichlorvos 76%. The compound, for adjuvant therapy of the swelling, was injected directly by the patient. Initial symptoms included vomiting, abdominal pain, and excessive secretions, which were subsequently followed by neuromuscular weakness. In the wake of their assessment, the patient's care protocol incorporated intubation and the application of atropine and pralidoxime. Anti-OP poisoning antidotes were unsuccessful in alleviating the patient's condition, which was linked to the depot of the poison compound. read more The patient's swelling was surgically excised, and immediate improvement was observed as a consequence of the treatment. The biopsy of the swelling confirmed the presence of granulomas and fungal hyphae. Following admission to the intensive care unit, the patient presented with intermediate syndrome, and was subsequently released after 20 days of hospitalization.
The Parenteral Insecticide Injection, The Toxic Depot, is a contribution from Jacob J, Reddy CHK, and James J. An article appearing in the 2022 seventh issue of Indian Journal of Critical Care Medicine, volume 26, covered pages 877 to 878.
Jacob J, Reddy CHK, and James J.'s joint work, 'The Toxic Depot Parenteral Insecticide Injection', is now available. read more The 2022 July edition of Indian Journal of Critical Care Medicine contained articles on pages 877-878.
The lungs are disproportionately affected by coronavirus disease-2019 (COVID-19). A breakdown in the respiratory system is a critical aspect of the negative health outcomes and fatalities stemming from COVID-19. While pneumothorax is a relatively uncommon complication in COVID-19 cases, its presence significantly hinders the patient's clinical progress. This case series of 10 patients with COVID-19 will summarize the epidemiological, demographic, and clinical characteristics, including those who subsequently developed pneumothorax.
All cases of COVID-19 pneumonia meeting the inclusion criteria and diagnosed between May 1, 2020, and August 30, 2020 at our center, and further complicated by pneumothorax, were included in our study. This case series involved a detailed analysis of their clinical records, and the subsequent compilation of epidemiological, demographic, and clinical data for these patients.
In our study, all patients required intensive care unit (ICU) treatment; of these, 60% benefited from non-invasive mechanical ventilation, while 40% ultimately necessitated intubation and invasive mechanical ventilation. Of the patients included in our study, a substantial 70% saw a positive resolution, leaving 30% who unfortunately passed away from the disease.
The epidemiological, demographic, and clinical profiles of COVID-19 patients, who had a complication of pneumothorax, were analyzed. The results of our study suggest that pneumothorax developed in a subset of patients who did not receive mechanical ventilation, implying it as a secondary complication of SARS-CoV-2 infection. The findings of our study also emphasize the fact that a majority of patients experiencing a complicated course due to pneumothorax still achieved a positive outcome, thereby illustrating the crucial need for timely and sufficient interventions in such circumstances.
NK Singh, a person. A study of the epidemiological and clinical aspects of pneumothorax in adult COVID-19 patients. Pages 833 to 835 of the 2022 seventh volume of the Indian Journal of Critical Care Medicine.
N.K. Singh Adults with Coronavirus Disease 2019: An Examination of Epidemiological and Clinical Manifestations, with a focus on those cases complicated by Pneumothorax. Volume 26, issue 7 of the Indian Journal of Critical Care Medicine in 2022, presented articles that spanned the pages from 833 to 835.
Developing nations face the significant health and economic consequences of deliberate self-harm on patients and their families.
Through a retrospective approach, this study examines hospital costs and the variables impacting medical expenditure. Among the participants, adult patients diagnosed with DSH were chosen.
Among the 107 patients investigated, pesticide consumption was the predominant type of poisoning, noted at a rate of 355 percent, followed by a significant 318 percent of cases involving tablet overdoses. The demographic analysis revealed a male majority with a mean age of 3004 years, and a standard deviation of 903 years. The middle ground for admission costs was 13690 USD (19557); compared to DSH methods that didn't include pesticides, DSH with pesticides increased care expenses by 67%. The cost of treatment was elevated due to the demand for intensive care, mechanical ventilation, the utilization of vasopressors, and the development of ventilator-associated pneumonia (VAP).
Pesticide-related poisoning is the most prevalent reason for DSH occurrences. Hospitalization costs for pesticide poisoning, when compared to other forms of DSH, tend to be notably higher and more direct.
Barnabas R., Yadav B., Jayakaran J., Gunasekaran K., Johnson J., and Pichamuthu K.
Direct healthcare costs for patients with self-inflicted harm in a South Indian tertiary care hospital are explored in this pilot study.